Motif Bio is seeking commercialization partners for iclaprim in Asia, Canada, Europe and Latin America. Novel antibiotics in clinical development, targeting serious and life-threatening infections, are also of interest for partnering. For further information, use the form below or contact

Motif Bio plc

27/28 Eastcastle Street
London, W1W 8DH
United Kingdom

Motif BioSciences Inc.

125 Park Avenue
25th Floor, Suite 2622
New York, NY 10017
United States